CDTX - Cidara Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CDTX is currently covered by 4 analysts with an average price target of $81.7. This is a potential upside of $16.08 (24.5%) from yesterday's end of day stock price of $65.62.

Cidara Therapeutics's activity chart (see below) currently has 14 price targets and 39 ratings on display. The stock rating distribution of CDTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.61% with an average time for these price targets to be met of 41.5 days.

Highest price target for CDTX is $54, Lowest price target is $35, average price target is $44.5.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 23-Jun-2025. First documented stock forecast 11-May-2015.

Currently out of the existing stock ratings of CDTX, 23 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$54

$-11.62 (-17.71%)

$36

2 months 22 days ago
(23-Jun-2025)

8/8 (100%)

$9.05 (20.13%)

109

Buy

$35

$-30.62 (-46.66%)

$24

6 months 4 days ago
(10-Mar-2025)

5/17 (29.41%)

$12.61 (56.32%)

94

Buy

1 years 1 months ago
(14-Aug-2024)

0/2 (0%)

$-15.8 (-75.96%)

Buy

3 years 5 months 1 days ago
(14-Apr-2022)

1/1 (100%)

$-2.15 (-14.19%)

158

Buy

$8

3 years 5 months 1 days ago
(14-Apr-2022)

0/3 (0%)

$6.41 (284.34%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CDTX (Cidara Therapeutics) average time for price targets to be met?

On average it took 41.5 days on average for the stock forecasts to be realized with a an average price target met ratio 29.61

Which analyst has the current highest performing score on CDTX (Cidara Therapeutics) with a proven track record?

JOSEPH STRINGER

Which analyst has the most public recommendations on CDTX (Cidara Therapeutics)?

Joseph Stringer works at NEEDHAM and has 3 price targets and 5 ratings on CDTX

Which analyst is the currently most bullish on CDTX (Cidara Therapeutics)?

Robert Driscoll with highest potential upside - $76.06

Which analyst is the currently most reserved on CDTX (Cidara Therapeutics)?

Ed Arce with lowest potential downside - -$30.62

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?